136 related articles for article (PubMed ID: 27084448)
1. Crystal structure of human PCNA in complex with the PIP box of DVC1.
Wang Y; Xu M; Jiang T
Biochem Biophys Res Commun; 2016 May; 474(2):264-270. PubMed ID: 27084448
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for novel interactions between human translesion synthesis polymerases and proliferating cell nuclear antigen.
Hishiki A; Hashimoto H; Hanafusa T; Kamei K; Ohashi E; Shimizu T; Ohmori H; Sato M
J Biol Chem; 2009 Apr; 284(16):10552-60. PubMed ID: 19208623
[TBL] [Abstract][Full Text] [Related]
3. NMR mapping of PCNA interaction with translesion synthesis DNA polymerase Rev1 mediated by Rev1-BRCT domain.
Pustovalova Y; Maciejewski MW; Korzhnev DM
J Mol Biol; 2013 Sep; 425(17):3091-105. PubMed ID: 23747975
[TBL] [Abstract][Full Text] [Related]
4. Structure insights into the molecular mechanism of the interaction between UHRF2 and PCNA.
Chen W; Wu M; Hang T; Wang C; Zhang X; Zang J
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):575-580. PubMed ID: 28951215
[TBL] [Abstract][Full Text] [Related]
5. DVC1 (C1orf124) recruits the p97 protein segregase to sites of DNA damage.
Davis EJ; Lachaud C; Appleton P; Macartney TJ; Näthke I; Rouse J
Nat Struct Mol Biol; 2012 Nov; 19(11):1093-100. PubMed ID: 23042607
[TBL] [Abstract][Full Text] [Related]
6. DVC1 (C1orf124) is a DNA damage-targeting p97 adaptor that promotes ubiquitin-dependent responses to replication blocks.
Mosbech A; Gibbs-Seymour I; Kagias K; Thorslund T; Beli P; Povlsen L; Nielsen SV; Smedegaard S; Sedgwick G; Lukas C; Hartmann-Petersen R; Lukas J; Choudhary C; Pocock R; Bekker-Jensen S; Mailand N
Nat Struct Mol Biol; 2012 Nov; 19(11):1084-92. PubMed ID: 23042605
[TBL] [Abstract][Full Text] [Related]
7. Structure of PCNA in complex with DNMT1 PIP box reveals the basis for the molecular mechanism of the interaction.
Jimenji T; Matsumura R; Kori S; Arita K
Biochem Biophys Res Commun; 2019 Aug; 516(2):578-583. PubMed ID: 31235252
[TBL] [Abstract][Full Text] [Related]
8. Targeting PCNA with Peptide Mimetics for Therapeutic Purposes.
Horsfall AJ; Abell AD; Bruning JB
Chembiochem; 2020 Feb; 21(4):442-450. PubMed ID: 31247123
[TBL] [Abstract][Full Text] [Related]
9. Physical interaction between proliferating cell nuclear antigen and replication factor C from Pyrococcus furiosus.
Matsumiya S; Ishino S; Ishino Y; Morikawa K
Genes Cells; 2002 Sep; 7(9):911-22. PubMed ID: 12296822
[TBL] [Abstract][Full Text] [Related]
10. Rational Design of a 3
Wegener KL; McGrath AE; Dixon NE; Oakley AJ; Scanlon DB; Abell AD; Bruning JB
Chemistry; 2018 Aug; 24(44):11325-11331. PubMed ID: 29917264
[TBL] [Abstract][Full Text] [Related]
11. Initial crystallographic study of human PCNA in complex with a peptide containing the noncanonical PIP-box sequence of human DNA polymerase iota.
Hishiki A; Shimizu T; Hanafusa T; Ohmori H; Sato M; Hashimoto H
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Oct; 64(Pt 10):954-6. PubMed ID: 18931444
[TBL] [Abstract][Full Text] [Related]
12. Unlocking the PIP-box: A peptide library reveals interactions that drive high-affinity binding to human PCNA.
Horsfall AJ; Vandborg BA; Kowalczyk W; Chav T; Scanlon DB; Abell AD; Bruning JB
J Biol Chem; 2021; 296():100773. PubMed ID: 33984330
[TBL] [Abstract][Full Text] [Related]
13. A small protein inhibits proliferating cell nuclear antigen by breaking the DNA clamp.
Altieri AS; Ladner JE; Li Z; Robinson H; Sallman ZF; Marino JP; Kelman Z
Nucleic Acids Res; 2016 Jul; 44(13):6232-41. PubMed ID: 27141962
[TBL] [Abstract][Full Text] [Related]
14. A site-selective, irreversible inhibitor of the DNA replication auxiliary factor proliferating cell nuclear antigen (PCNA).
Evison BJ; Actis ML; Wu SZ; Shao Y; Heath RJ; Yang L; Fujii N
Bioorg Med Chem; 2014 Nov; 22(22):6333-43. PubMed ID: 25438756
[TBL] [Abstract][Full Text] [Related]
15. Small molecule inhibitors of PCNA/PIP-box interaction suppress translesion DNA synthesis.
Actis M; Inoue A; Evison B; Perry S; Punchihewa C; Fujii N
Bioorg Med Chem; 2013 Apr; 21(7):1972-7. PubMed ID: 23395113
[TBL] [Abstract][Full Text] [Related]
16. p21 Exploits Residue Tyr151 as a Tether for High-Affinity PCNA Binding.
Kroker AJ; Bruning JB
Biochemistry; 2015 Jun; 54(22):3483-93. PubMed ID: 25972089
[TBL] [Abstract][Full Text] [Related]
17. The p12 subunit of human polymerase δ uses an atypical PIP box for molecular recognition of proliferating cell nuclear antigen (PCNA).
Gonzalez-Magaña A; Ibáñez de Opakua A; Romano-Moreno M; Murciano-Calles J; Merino N; Luque I; Rojas AL; Onesti S; Blanco FJ; De Biasio A
J Biol Chem; 2019 Mar; 294(11):3947-3956. PubMed ID: 30655288
[TBL] [Abstract][Full Text] [Related]
18. The interaction between ubiquitin and yeast polymerase η C terminus does not require the UBZ domain.
Duong PTM; Bui ATN; Kim SO; Park HS; Seo YS; Choi BS
FEBS Lett; 2020 Jun; 594(11):1726-1737. PubMed ID: 32239506
[TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen (PCNA) interactions in solution studied by NMR.
De Biasio A; Campos-Olivas R; Sánchez R; López-Alonso JP; Pantoja-Uceda D; Merino N; Villate M; Martin-Garcia JM; Castillo F; Luque I; Blanco FJ
PLoS One; 2012; 7(11):e48390. PubMed ID: 23139781
[TBL] [Abstract][Full Text] [Related]
20. Docking of a specialized PIP Box onto chromatin-bound PCNA creates a degron for the ubiquitin ligase CRL4Cdt2.
Havens CG; Walter JC
Mol Cell; 2009 Jul; 35(1):93-104. PubMed ID: 19595719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
